Jefferies Upgrades Novartis (NVS) to Buy

Jefferies upgraded Novartis (NYSE: NVS) from Hold to Buy.

Analyst Jeffrey Holford comments, "Updating for recent transactions and increased visibility on LCZ696 sees our EPS estimates raised by 3-10% leaving us 2-8% ahead of consensus in the mid to long term. With a refocused business going forward and positive earnings momentum expected, we raise the stock to a Buy with a PT of CHF87."

For an analyst ratings summary and ratings history on Novartis click here. For more ratings news on Novartis click here.

Shares of Novartis closed at $87.00 yesterday.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• JPMorgan Upgrades FOX Corp. (FOXA) to Overweight
• Kepler Cheuvreux Upgrades Swissquote Group Holding SA (SQN:SW) to Buy